Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71251 - 71275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	KCNAB2	8514	upregulated	Silicon Dioxide analog results in increased expression of KCNAB2 mRNA	1p36.31	A24195
Silicon dioxide	Approved	KCNB1	3745	upregulated	Silicon Dioxide analog results in increased expression of KCNB1 mRNA	20q13.13	A24195
Silicon dioxide	Approved	KCNC1	3746	downregulated	Silicon Dioxide analog results in decreased expression of KCNC1 mRNA	11p15.1	A24194
Silicon dioxide	Approved	KCNC1	3746	upregulated	Silicon Dioxide analog results in increased expression of KCNC1 mRNA	11p15.1	A24195
Silicon dioxide	Approved	KCND1	3750	downregulated	Silicon Dioxide analog results in decreased expression of KCND1 mRNA	Xp11.23	A24195
Silicon dioxide	Approved	KCNE2	9992	upregulated	Silicon Dioxide analog results in increased expression of KCNE2 mRNA	21q22.11	A24194
Silicon dioxide	Approved	KCNE2	9992	downregulated	Silicon Dioxide results in decreased expression of KCNE2 mRNA	21q22.11	A24196
Silicon dioxide	Approved	KCNE3	10008	downregulated	Silicon Dioxide analog results in decreased expression of KCNE3 mRNA	11q13.4	A24195
Silicon dioxide	Approved	KCNE5	23630	upregulated	Silicon Dioxide analog results in increased expression of KCNE5 mRNA	Xq23	A24195
Silicon dioxide	Approved	KCNG1	3755	upregulated	Silicon Dioxide analog results in increased expression of KCNG1 mRNA	20q13.13	A24194
Silicon dioxide	Approved	KCNG3	170850	upregulated	Silicon Dioxide analog results in increased expression of KCNG3 mRNA	2p21	A24195
Silicon dioxide	Approved	KCNH7	90134	upregulated	Silicon Dioxide analog results in increased expression of KCNH7 mRNA	2q24.2	A24194
Silicon dioxide	Approved	KCNJ11	3767	downregulated	Silicon Dioxide analog results in decreased expression of KCNJ11 mRNA	11p15.1	A24195
Silicon dioxide	Approved	KCNJ12	3768	upregulated	Silicon Dioxide analog results in increased expression of KCNJ12 mRNA	17p11.2	A24194
Silicon dioxide	Approved	KCNJ13	3769	upregulated	Silicon Dioxide analog results in increased expression of KCNJ13 mRNA	2q37.1	A24195
Silicon dioxide	Approved	KCNJ16	3773	downregulated	Silicon Dioxide analog results in decreased expression of KCNJ16 mRNA	17q24.3	A24195
Silicon dioxide	Approved	KCNJ16	3773	downregulated	Silicon Dioxide results in decreased expression of KCNJ16 mRNA	17q24.3	A24197
Silicon dioxide	Approved	KCNJ2	3759	downregulated	Silicon Dioxide analog results in decreased expression of KCNJ2 mRNA	17q24.3	A24195
Silicon dioxide	Approved	KCNJ4	3761	downregulated	Silicon Dioxide analog results in decreased expression of KCNJ4 mRNA	22q13.1	A24195
Silicon dioxide	Approved	KCNJ8	3764	downregulated	Silicon Dioxide analog results in decreased expression of KCNJ8 mRNA	12p12.1	A24195
Silicon dioxide	Approved	KCNK1	3775	upregulated	Silicon Dioxide analog results in increased expression of KCNK1 mRNA	1q42.2	A24194
Silicon dioxide	Approved	KCNK3	3777	downregulated	Silicon Dioxide analog results in decreased expression of KCNK3 mRNA	2p23.3	A24195
Silicon dioxide	Approved	KCNK5	8645	downregulated	Silicon Dioxide analog results in decreased expression of KCNK5 mRNA	6p21.2	A24195
Silicon dioxide	Approved	KCNMA1	3778	upregulated	Silicon Dioxide analog results in increased expression of KCNMA1 mRNA	10q22.3	A24195
Silicon dioxide	Approved	KCNMB4	27345	downregulated	Silicon Dioxide analog results in decreased expression of KCNMB4 mRNA	12q15	A24195

Displaying entries 71251 - 71275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability